Clinical Trials
3 trialsNCT06663046 2026-05-07
Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT04505813 2024-01-16
Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma
NexImmune Inc.
Phase 1/2 Suspended
NCT03752541 2022-05-20
Efficacy and Safety Evaluation of BCMA-UCART
Bioray Laboratories
Phase NA Suspended